113 related articles for article (PubMed ID: 24190503)
1. Test systems of developmental toxicity: state-of-the art and future perspectives.
Leist M; Ringwald A; Kolde R; Bremer S; van Thriel C; Krause KH; Rahnenführer J; Sachinidis A; Hescheler J; Hengstler JG
Arch Toxicol; 2013 Dec; 87(12):2037-42. PubMed ID: 24190503
[No Abstract] [Full Text] [Related]
2. Behavioral Teratogenesis in Drosophila melanogaster.
Mishra M; Barik BK
Methods Mol Biol; 2018; 1797():277-298. PubMed ID: 29896698
[TBL] [Abstract][Full Text] [Related]
3. Exposure-based validation list for developmental toxicity screening assays.
Daston GP; Beyer BK; Carney EW; Chapin RE; Friedman JM; Piersma AH; Rogers JM; Scialli AR
Birth Defects Res B Dev Reprod Toxicol; 2014 Dec; 101(6):423-8. PubMed ID: 25475026
[TBL] [Abstract][Full Text] [Related]
4. Laboratory models and their role in assessing teratogenesis.
Daston GP
Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):183-7. PubMed ID: 21766439
[TBL] [Abstract][Full Text] [Related]
5. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
Fort DJ; Stover EL; Farmer DR; Lemen JK
Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
[TBL] [Abstract][Full Text] [Related]
6. 57th Annual Meeting of the Japanese Teratology Society: Seeking a contact between humans and experimental animals.
Aoyama H
Congenit Anom (Kyoto); 2017 Nov; 57(6):176-177. PubMed ID: 29105191
[No Abstract] [Full Text] [Related]
7. Developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions.
Martin PL; Weinbauer GF
Int J Toxicol; 2010 Dec; 29(6):552-68. PubMed ID: 20926830
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of teratogenesis: suggestions from animal studies.
Giavini E; Menegola E
Reprod Toxicol; 2012 Sep; 34(2):180-5. PubMed ID: 22610102
[TBL] [Abstract][Full Text] [Related]
9. Assembling systems biology, embryo development and teratogenesis: What do we know so far and where to go next?
Kowalski TW; Dupont ÁV; Rengel BD; Sgarioni E; Gomes JDA; Fraga LR; Schuler-Faccini L; Vianna FSL
Reprod Toxicol; 2019 Sep; 88():67-75. PubMed ID: 31362043
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility to teratogens: state of the art.
Cassina M; Salviati L; Di Gianantonio E; Clementi M
Reprod Toxicol; 2012 Sep; 34(2):186-91. PubMed ID: 22659091
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of developmental toxicity studies in rat and rabbit: what is the added value of the rabbit as an additional test species?
Janer G; Slob W; Hakkert BC; Vermeire T; Piersma AH
Regul Toxicol Pharmacol; 2008 Mar; 50(2):206-17. PubMed ID: 18171599
[TBL] [Abstract][Full Text] [Related]
12. Background for two perspectives on the status and prospects of in vitro and short-term prescreening tests for developmental toxicity hazard potential.
Welsch F
Teratology; 1996 Jun; 53(6):332-3. PubMed ID: 8910977
[No Abstract] [Full Text] [Related]
13. Oxidative stress as a mechanism of teratogenesis.
Hansen JM
Birth Defects Res C Embryo Today; 2006 Dec; 78(4):293-307. PubMed ID: 17315243
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthesis enhances teratogenic effects induced by valproic Acid.
Tiboni GM; Chiarelli F; Verrotti A
In Vivo; 2013; 27(4):513-8. PubMed ID: 23812222
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the predictive validity of Frog Embryo Teratogenesis Assay--Xenopus (FETAX).
Fort DJ; Paul RR
J Appl Toxicol; 2002; 22(3):185-91. PubMed ID: 12015799
[TBL] [Abstract][Full Text] [Related]
16. Struggles for equivalence: in vitro developmental toxicity model evolution in pharmaceuticals in 2006.
Chapin R; Stedman D; Paquette J; Streck R; Kumpf S; Deng S
Toxicol In Vitro; 2007 Dec; 21(8):1545-51. PubMed ID: 17137747
[TBL] [Abstract][Full Text] [Related]
17. In vitro tests in screening teratogens: considerations to aid the validation process.
Kimmel GL
Prog Clin Biol Res; 1985; 163C():259-63. PubMed ID: 3991628
[TBL] [Abstract][Full Text] [Related]
18. Teratogenic mechanisms associated with prenatal medication exposure.
van Gelder MM; van Rooij IA; de Jong-van den Berg LT; Roeleveld N
Therapie; 2014; 69(1):13-24. PubMed ID: 24698184
[TBL] [Abstract][Full Text] [Related]
19. Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds.
Selderslaghs IW; Blust R; Witters HE
Reprod Toxicol; 2012 Apr; 33(2):142-54. PubMed ID: 21871558
[TBL] [Abstract][Full Text] [Related]
20. Validation of alternative methods for developmental toxicity testing.
Piersma AH
Toxicol Lett; 2004 Apr; 149(1-3):147-53. PubMed ID: 15093260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
